Oct 19th, 2022
The 2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure
Get the latest information on the 2022 HF clinical practice guidelines.
The 2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure: Executive Summary
Nov. 7 | 9:30-10:30 a.m. | Main Event I
Heart failure (HF) remains a leading cause of cardiovascular morbidity and mortality globally. In the U.S., HF is the leading cause of hospitalization among adults over age 65. There has been an explosion of novel evidence-based drug therapy for HFrEF, HFmrEF and HFpEF, with recommendations that have now been synthesized into the updated 2022 HF clinical practice guidelines.